Drug details

Skytrofa (lonapegsomatropin-tcgd for injection)

type of Growth Hormone Analogs

Skytrofa (lonapegsomatropin-tcgd) is a human growth hormone used to treat pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• diarrhea,
• easy bruising,
• unusual bleeding,
• abdominal pain, and
• joint pain and swelling,

The following drugs are related to Skytrofa, either as a replacement or used together:

• Egrifta (tesamorelin injection)
• Egrifta SV (tesamorelin for injection)
• Genotropin (somatropin [rdna origin])
• Humatrope (somatropin rdna origin)
• Ngenla (somatrogon-ghla injection)
• Norditropin (somatropin injection)
• Nutropin (somatropin (rdna origin) for inj)
• Nutropin AQ (somatropin (rdna origin))
• Nutropin Depot (somatropin (rdna origin) for inj)
• Omnitrope (somatropin [ rdna origin] injection)
• Saizen (somatropin injection)
• Sogroya (somapacitan-beco injection)
• Zorbtive (somatropin rdna origin for injection)
• Tev-Tropin (somatropin, rdna origin, for injection)